LOINC
Version 2.73

1045-4Deprecated H NOS Ab [Presence] in Serum or Plasma from Blood product unitDeprecated

Status Information

Status
Deprecated
Reason
Ambiguous
Comment
The use of 'NOS' in the Component does not make sense.
Map-To Long Common Name Mapping Guidance
1042-1 H Ab [Presence] in Serum or Plasma from Blood product unit

Part Description

LP14636-2   H NOS
The H antigen is produced by a specific fucosyltransferase. Depending upon a person's ABO blood type, the H antigen is converted into either the A antigen, B antigen, or both. If a person has blood group O, the H antigen remains unmodified. Therefore, the H antigen is present in the highest amounts in blood type O and in the least amounts in blood type AB. The history and biochemical nature of the H antigen is entangled with that of the ABO and Lewis blood group systems. The recognition of the Hh blood group probably begins with the discovery by Bhende et al. (1952) of the first three individuals who completely lacked A and B antigens but were not group O. This null phenotype was named "Bombay" after the city where it was found. Although the Bombay phenotype is extremely rare in most populations, a number of examples have been found in India over the years. Early suggestions were that this type was due to a new allele at the ABO locus, but others suggested an inhibitor gene and finally the possibility of a genetically independent but related gene. We now know that the Bombay phenotype is due to a recessive gene at the H locus; ie. h and is therefore referred to as Oh. Subsequently, intermediate form of the H gene have been found and these individuals are called "para-Bombays". Source: National Library of Medicine, H NOS

Fully-Specified Name

Component
H NOS Ab
Property
PrThr
Time
Pt
System
Ser/Plas^BPU
Scale
Ord
Method

Additional Names

Short Name
Deprecated H NOS Ab SerPl BPU Ql
Display Name
H NOS Ab Ql (S/P BPU)
Consumer Name Alpha
H NOS antibody, Blood Product Unit

Basic Attributes

Class
BLDBK
Type
Laboratory
First Released
Version 1.0
Last Updated
Version 2.65
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. Test ambiguous.
Order vs. Observation
Observation

Language Variants Get Info

zh-CNChinese (China)
H 型 未作说明的 抗体:存在情况或阈值:时间点:血清/血浆^血液制品单位:序数型:
nl-NLDutch (Netherlands)
H NOS As:aanwezigheid:moment:serum of plasma^bloedproducteenheid:ordinaal:
fr-BEFrench (Belgium)
H SAI Ac:PrThr:Temps ponctuel:Sérum/Plasma^Unité de produit sanguin:Ordinal:
fr-CAFrench (Canada)
H NS , Ac:Présence-Seuil:Temps ponctuel:Sérum/Plasma^Unité de produit sanguin:Ordinal:
it-ITItalian (Italy)
H NAS Ab:PrThr:Pt:Siero/Plasma^Unità prodotto sangue:Ord:
ko-KRKorean (Korea, Republic of)
달리 명시되지 않은 H 항체:임의농도:검사시점:혈청/혈장^혈액제제단위:순위척도:
pt-BRPortuguese (Brazil)
H NOS Ac:ACnc:Pt:Sor/Plas^bolsa de sangue:Ord:
ru-RURussian (Russian Federation)
H не указанный в другом месте Ат:PrThr:ТчкВрм:Сыв/Плаз^КПЕ:Пор:
es-ARSpanish (Argentina)
[anticuerpo anti - ] H, sin otra especificación [Ac]:concentración arbitraria:punto en el tiempo:suero/plasma^unidad de hemoderivado:ordinal:
es-MXSpanish (Mexico)
H NOS Ab:Presencia o umbral:Punto temporal:Suero o plasma ^ Unidad de hemoderivado:Ordinal:
es-ESSpanish (Spain)
H NOS Anticuerpos:PrThr:Punto temporal:Suero o Plasma^Unidad de hemoderivado:Ord:
tr-TRTurkish (Turkey)
H NOS Ab:MevcEşik:Zmlı:Ser/Plaz^KanÜrÜ:Srl:

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=1045-4